Microfluidic Obstacle Arrays for Rare-Cell Enrichment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell separation techniques, such as flow cytometry and cell sorting, require large and expensive equipment, large sample volumes, and skilled operators, and often fail to enrich samples sufficiently for analyzing rare components, leading to unacceptable losses and inefficiencies.

Innovation Solution

Devices featuring arrays of obstacles that deterministically deflect particles based on hydrodynamic size, using structures that divide fluid flow unequally to direct particles into major or minor fluxes, allowing for enrichment and alteration of samples, including microfluidic channels and methods for preferential lysis of specific cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If flow cytometry and cell sorting methods are used, then cell separation is achieved, but the equipment is large and expensive, requiring large sample volumes and skilled operators

Engineering Contradiction:
Improvecell separation capabilityVSAvoidequipment size and cost
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The device segments the flow cytometry function into discrete microfabricated components: microchannels, obstacle arrays, and collection chambers. This segmentation enables the complex separation function to be achieved through simple geometric structures rather than expensive commercial instruments

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates a simplified copy of flow cytometry functionality using microfabricated obstacle arrays that replicate the cell deflection and separation principles of commercial flow cytometers, but in a miniaturized, low-cost format suitable for point-of-care applications

Inventive Principle:
Principle #26Copying

2Measurement precision

If conventional cell sorting techniques are employed, then cell separation is performed, but sample volume requirements are large

Engineering Contradiction:
Improvecell separation capabilityVSAvoidsample volume
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The invention transitions from macro-scale flow cytometry to micro-scale dimensions, using microchannels with characteristic dimensions of 10-100 micrometers. This dimensional change enables sufficient cell separation with much smaller sample volumes, making the technique suitable for precious or limited clinical samples

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If electrostatic deflection, centrifugation, FACS, or MACS methods are used, then cell separation is achieved, but rare components cannot be enriched sufficiently

Engineering Contradiction:
Improvecell separation capabilityVSAvoidenrichment precision
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The device creates local quality variations through obstacle arrays with specifically designed gap sizes and patterns. Cells of different sizes experience different local flow conditions as they pass through gaps of varying dimensions, enabling precise size-based separation and enrichment of rare cell populations with high resolution

Inventive Principle:
Principle #3Local quality

4Measurement precision

If conventional separation techniques are used, then cell separation is performed, but unacceptable losses occur through inefficient separation or degradation

Engineering Contradiction:
Improvecell separation capabilityVSAvoidcell loss
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

The invention replaces harsh mechanical separation forces (centrifugation, electrostatic deflection) with gentle microfluidic flow dynamics. Cells are separated based on passive hydrodynamic interactions with obstacle arrays, eliminating mechanical stress that causes cell degradation and minimizing losses of rare and fragile cell populations

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enriches samples by increasing the relative population of target cells by up to 1,000,000-fold, reduces mechanical stress on cells, and allows for efficient separation and alteration of rare cells with high precision and low equipment costs.

Implementation Method 1

structures that deterministically deflect particles, in a fluid, having a hydrodynamic size above a critical size in a direction not parallel to the average direction of flow of the fluid in the structure

Methodology Applied
Scientific EffectDeterministic lateral displacement:

Implementation Method 2

particles having a hydrodynamic size above a critical size... the particles are directed into the major flux

Methodology Applied
Scientific EffectHydrodynamic size-based separation:

Data Source

PatentUS12409457B2Devices and method for enrichment and alteration of cells and other particles
Publication Date: 2025.09.09 ZEON CORP
  • US12409457B2 patent drawing
  • US12409457B2 patent drawing
  • US12409457B2 patent drawing

AI summary

The invention features devices and methods for the deterministic separation of particles. Exemplary methods include the enrichment of a sample in a desired particle or the alteration of a desired particle in the device. The devices and methods are advantageously employed to enrich for rare cells, e.g., fetal cells, present in a sample, e.g., maternal blood and rare cell components, e.g., fetal cell nuclei. The invention further provides a method for preferentially lysing cells of interest in a sample, e.g., to extract clinical information from a cellular component, e.g., a nucleus, of the cells of interest. In general, the method employs differential lysis between the cells of interest and other cells (e.g., other nucleated cells) in the sample.